Fibrin sealant patch (TachoSil) vs oxidized regenerated cellulose patch (Surgicel Original) for the secondary treatment of local bleeding in patients undergoing hepatic resection: a randomized controlled trial. J Am Coll Surg 2012; 222: 261-268.
Published: 5th October 2016
Authors: Genyk Y, Kato T, Pomposelli JJ, Wright Jr JK, Sher LS, Tetens V et al.
Some 224 with moderate to severe bleeding after hepatic resection were included. Fibrin sealant reduced the rate of bleeding after 3 min and 5 min (both P<0.001) compared to Surgicel. A total of 10.9 per cent of patients in the Surgicel group needed further haemostatic treatment.Pubmed Link
You may also be interested in
Antiviral therapy reduces hepatocellular carcinoma recurrence in patients with low HBV-DNA levels. A randomized controlled trial. Ann Surg 2018: 268: 943-954.
Authors: Huang G, Li P-P, Lau WY, Pan Z-Y, Zhao L-H, Wang Z-G et al.
Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst 2017; 109. doi: 10.1093/jnci/djx015.
Authors: Ruers T, Van Coevorden F, Punt CJA, Pierie J-PEN, Borel-Rinkes I, Ledermann JA et al.
Fibrin sealant with polyglycolic acid felt vs fibrinogen-based collagen fleece at the liver cut surface for prevention of postoperative bile leakage and hemorrhage: a prospective, randomized, controlled study. J Am Coll Surg 2016; 222: 59-64.
Authors: Kobayashi S, Takeda Y, Nakahira S, Tsujie M, Shimizu J, Miyamoto A et al.
Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial. Ann Surg 2015; 261: 56-66.
Authors: Huang G, Lau WY, Wang Z-G, Pan Z-Y, Yuan S-X, Feng S et al. et al.
Adjuvant radiotherapy in centrally located hepatocellular carcinomas after hepatectomy with narrow margin (<1cm): a prospective randomized study. J Am Coll Surg 2014; 218: 381-392.
Authors: Yu W, Wang W, Rong W, Wang L, Xu Q, Wu F et al. et al.
Adjuvant hepatic intra-arterial iodine 131- lipiodol following curative resection of hepatocellular carcinoma: a prospective randomized trial. World J Surg 2013; 37: 1356-1361.
Authors: Chung AY, Ooi LL, Machin D, Tan SB, Goh BK, Wong JS et al. et al.
Radiofrequency ablation with or without transcatheter chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 2013; 31: 426-432.
Authors: Peng Z-W, Zhang Y-J, Chen M-S, Xu L, Lian H-L, Lin X-J et al. et al.
Effects of pentoxifylline on liver regeneration: a double blinded, randomized clinical trial in 101 patients undergoing major liver resection. Ann Surg 2010; 252: 813-822.
Authors: Petrowsky H, Breitenstein S, Slankamenac K, Vetter D, Lechmann K, Heinrich S et al. et al.
A prospective randomized controlled trial of preoperative transarterial chemoembolisation for resectable large hepatocellular carcinoma Ann Surg 2009; 249: 195-202
Authors: Zhou W-P, Lai ECH, Li A-J, Fu S-Y, Zhou J-Ppan Z-y et al
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for respectable liver metastases from colorectal cancer (EORTC Intergroup Trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-1016.
Authors: Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P et al.
Chemoprevention of primary liver cancer: a double blind trial in Linxian, China. J Natl Cancer Inst 2007; 99: 1240-1247.
Authors: Qu C-X, Kamangar F, Fan J-H, Yu B, Sun X-D, Taylor PR et al.